Mirae Asset Global Investments Co., Ltd. Kura Oncology, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,772 shares of KURA stock, worth $48,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,772
Previous 2,274
21.9%
Holding current value
$48,676
Previous $46,000
17.39%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding KURA
# of Institutions
185Shares Held
79.6MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$124 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$122 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$102 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$95 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$79.7 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.17B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...